LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

The role of enzymes as key enablers in the green transition and in enabling the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance

08/09/2022
POSITION PAPER
ABSTRACT
The objective of this paper is to highlight the role of enzymes as key enablers in the green transition, including the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance (SF).

The paper recommends key elements to be amended in the draft technical screening criteria developed for the manufacture of chemicals and chemical products by the Sustainable Finance Platform (SFP). AMFEP welcomes the Commission’s objective of a taxonomy of sustainable investments. The work to develop a common definition of what constitutes a sustainable investment is crucial to incentivise investments in sustainable solutions contributing to the six environmental and climate objectives of the EU Green Deal.

The report on preliminary recommendations on technical screening criteria for environmental objec-tives 3-6 of the EU taxonomy published on 30 March 2022 by the SFP (herein after the Draft Criteria), however, overlooks the documented positive environmental benefits of enzymes. Therefore, AMFEP would like to highlight the enormous contribution which enzymes have brought and will continue bringing to the EU for realising their green ambition.

What is the problem?
The current Draft Criteria excludes enzyme production from the definition of environmentally sustain-able activities under provision 2.1 “Manufacture of chemicals”. This exclusion is based solely on the fact that enzymes will be regarded as “substances of concern” (SoC) as they meet the classification criteria for respiratory sensitisation. However, enzymes have for decades been used safely by workers due to product design and guidance, and no consumer incidents have been reported in Europe for the last 50 years.

In addition, the preliminary recommendations set out in the draft Report of the SFP’s Technical Work-ing Group (TWG), published on 3 August 2021, excludes the production of enzyme-based chemical products from the definition of environmentally sustainable activities (2.4 “Manufacture of Chemical Products”).

Excluding biologically produced enzymes from the criteria due to this SoC listing would conflict with other EU objectives in the EU Bioeconomy Strategy and related objectives for replacing chemicals with safe, bio-based, and sustainable alternatives. In addition, enzymes are critical and irreplaceable to achieve the aim of the Draft Criteria, “Substantial contribution to pollution prevention and control”.

Therefore, we encourage the EU to take a similar approach and recognise enzymes for their key role in reducing waste and effluents as well as the use of water, energy and raw materials, and derogate them from the exclusion of respiratory sensitisers from the criteria – as was done in EU Ecolabel and Nordic Ecolabel criteria for various products. Enzymes are already derogated from the exclusion of respiratory sensitisers from the criteria under 2.6 “Finishing of Textiles” in the Draft Criteria5 for the same reason.

Recommendation
Given the long history and ample evidence that enzymes are already used as substitutes for hazardous chemicals in a wide range of industrial and consumer products, contributing to the goals of the Taxonomy, AMFEP recommends that enzymes are derogated from the exclusion of “Substances of Concern” (SoCs) and products under activities 2.3 on the “Manufacture of Chemicals” and 2.4 on the “Manufacture of Chemical Products”20. Failure to do so will discourage investments in safe and sustainable alternatives to chemicals and go against the environmental objective of Pollution Prevention and Control. Enzymes, and the broader Bioeconomy, are key enablers in the green transition and should therefore be recognized as such in the EU Taxonomy.

Click on the button below to read the full position paper.

The role of enzymes as key enablers in the green transition and in enabling the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance


Download
2022_08_I_PP_AMFEP-EuropaBio-Position-on-TaxonomyDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.